Skip to main content
Top
Published in: Journal of Neurology 3/2016

01-03-2016 | Original Communication

Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings

Authors: Leyla Baysal-Kirac, Erdem Tuzun, Ece Erdag, Canan Ulusoy, Ebru Nur Vanli-Yavuz, Esme Ekizoglu, Sian Peach, Mine Sezgin, Nerses Bebek, Candan Gurses, Aysen Gokyigit, Angela Vincent, Betul Baykan

Published in: Journal of Neurology | Issue 3/2016

Login to get access

Abstract

Autonomic dysfunction has frequently been reported in autoimmune encephalitis associated with seizures and there is growing evidence that epilepsy patients may display neuronal autoantibodies (NAAb). The aim of this study was to investigate the frequency of NAAb in epilepsy patients with peri-ictal autonomic findings. Fifty-eight patients (37 women/21 men; average age of 34.2 ± 9.9 years and epilepsy duration of 19.1 ± 9.6 years) who had at least one video-EEG recorded focal or secondary generalized seizure with clear-cut documented peri-ictal autonomic findings, or consistently reported seizures with autonomic semiology, were included. NAAb were tested by RIA or cell based assays. NAAb were present in 17 of 58 (29.3 %) patients. Among seropositive patients, antibodies were directed against N-methyl-d-aspartate receptor (NMDAR) in 5 (29 %), contactin-associated protein-like 2 (CASPR2) in 5 (29 %), uncharacterized voltage gated potassium channel (VGKC)-complex antigens in 3 (18 %), glutamic acid decarboxylase (GAD) in 2 (12 %), glycine receptor (GLYR) in one (6 %) and type A gamma aminobutyric acid receptor (GABAAR) in one patient (6 %). Peri-ictal gastrointestinal manifestations, piloerection, ictal fever, urinary urge, and cough occurred more commonly in the seropositive group. The prevalences of psychotic attacks and status epilepticus were significantly increased in the seropositive group. Seropositivity prevalence in our patient group with peri-ictal autonomic findings is higher than other previously reported epilepsy cohorts. In our study, ictal fever-VGKC-complex antibody and pilomotor seizure-GABAAR antibody associations were documented for the first time. Chronic epilepsy patients with peri-ictal autonomic semiology, history of status epilepticus and psychotic disorder may benefit from autoantibody screening.
Literature
1.
go back to reference Shorvon S, Frederick A, Renzo G (2011) The causes of epilepsy: common and uncommon causes in adults and children. Cambridge University Press, CambridgeCrossRef Shorvon S, Frederick A, Renzo G (2011) The causes of epilepsy: common and uncommon causes in adults and children. Cambridge University Press, CambridgeCrossRef
2.
go back to reference McKnight K, Jiang Y, Hart Y, Cavey A, Wroe S, Blank M et al (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65:1730–1736CrossRefPubMed McKnight K, Jiang Y, Hart Y, Cavey A, Wroe S, Blank M et al (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65:1730–1736CrossRefPubMed
3.
go back to reference Majoie HJ, de Baets M, Renier W, Lang B, Vincent A (2006) Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res 71:135–141CrossRefPubMed Majoie HJ, de Baets M, Renier W, Lang B, Vincent A (2006) Antibodies to voltage-gated potassium and calcium channels in epilepsy. Epilepsy Res 71:135–141CrossRefPubMed
4.
go back to reference Quek AM, Britton JW, McKeon A, So E, Lennon VA, Shin C et al (2012) Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol 69:582–593CrossRefPubMedPubMedCentral Quek AM, Britton JW, McKeon A, So E, Lennon VA, Shin C et al (2012) Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol 69:582–593CrossRefPubMedPubMedCentral
5.
go back to reference Liimatainen S, Peltola M, Sabater L, Fallah M, Kharazmi E, Haapala AM et al (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51:760–767CrossRefPubMed Liimatainen S, Peltola M, Sabater L, Fallah M, Kharazmi E, Haapala AM et al (2010) Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 51:760–767CrossRefPubMed
6.
go back to reference Brenner T, Sills GJ, Hart Y, Howell S, Waters P, Brodie MJ et al (2013) Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 54:1028–1035CrossRefPubMed Brenner T, Sills GJ, Hart Y, Howell S, Waters P, Brodie MJ et al (2013) Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 54:1028–1035CrossRefPubMed
7.
go back to reference Suleiman J, Wright S, Gill D, Brilot F, Waters P, Peacock K et al (2013) Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies. Epilepsia 54:2091–2100CrossRefPubMed Suleiman J, Wright S, Gill D, Brilot F, Waters P, Peacock K et al (2013) Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies. Epilepsia 54:2091–2100CrossRefPubMed
8.
go back to reference Ekizoglu E, Tuzun E, Woodhall M, Lang B, Jacobson L, Icoz S et al (2014) Investigation of neuronal autoantibodies in two different focal epilepsy syndromes. Epilepsia 55:414–422CrossRefPubMed Ekizoglu E, Tuzun E, Woodhall M, Lang B, Jacobson L, Icoz S et al (2014) Investigation of neuronal autoantibodies in two different focal epilepsy syndromes. Epilepsia 55:414–422CrossRefPubMed
9.
go back to reference Irani SR, Buckley C, Vincent A, Cockerell OC, Rudge P, Johnson MR et al (2008) Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 71:1647–1648CrossRefPubMed Irani SR, Buckley C, Vincent A, Cockerell OC, Rudge P, Johnson MR et al (2008) Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 71:1647–1648CrossRefPubMed
10.
go back to reference Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS et al (2010) N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly nonparaneoplastic disorder of both sexes. Brain 133:1655–1667CrossRefPubMedPubMedCentral Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS et al (2010) N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly nonparaneoplastic disorder of both sexes. Brain 133:1655–1667CrossRefPubMedPubMedCentral
11.
go back to reference Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098CrossRefPubMedPubMedCentral Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M et al (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098CrossRefPubMedPubMedCentral
12.
go back to reference Wieser S, Kelemen A, Barsi P, Vincent A, Borbely C, Rasonyi G et al (2005) Pilomotor seizures and status in non-paraneoplastic limbic encephalitis. Epileptic Disord 7:205–211PubMed Wieser S, Kelemen A, Barsi P, Vincent A, Borbely C, Rasonyi G et al (2005) Pilomotor seizures and status in non-paraneoplastic limbic encephalitis. Epileptic Disord 7:205–211PubMed
13.
go back to reference Rocamora R, Becerra JL, Fossas P, Gomez M, Vivanco-Hidalgo RM, Mauri JA et al (2014) Pilomotor seizures: an autonomic semiology of limbic encephalitis? Seizure 3:670–673CrossRef Rocamora R, Becerra JL, Fossas P, Gomez M, Vivanco-Hidalgo RM, Mauri JA et al (2014) Pilomotor seizures: an autonomic semiology of limbic encephalitis? Seizure 3:670–673CrossRef
14.
go back to reference Barber PA, Anderson NE, Vincent A (2000) Morvan’s syndrome associated with voltage-gated K+ channel antibodies. Neurology 54:771–772CrossRefPubMed Barber PA, Anderson NE, Vincent A (2000) Morvan’s syndrome associated with voltage-gated K+ channel antibodies. Neurology 54:771–772CrossRefPubMed
15.
go back to reference Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P et al (2001) Morvan’s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 124:2417–2426CrossRefPubMed Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P et al (2001) Morvan’s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 124:2417–2426CrossRefPubMed
16.
go back to reference Zuliani L, Graus F, Giometto B, Bien C, Vincent A (2012) Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry 83:638–645CrossRefPubMedPubMedCentral Zuliani L, Graus F, Giometto B, Bien C, Vincent A (2012) Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition. J Neurol Neurosurg Psychiatry 83:638–645CrossRefPubMedPubMedCentral
17.
18.
go back to reference Blume WT, Luders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J Jr (2001) Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 42:1212–1218CrossRefPubMed Blume WT, Luders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J Jr (2001) Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 42:1212–1218CrossRefPubMed
19.
go back to reference Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W et al (2010) Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 51:676–685CrossRefPubMed Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W et al (2010) Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 51:676–685CrossRefPubMed
20.
go back to reference Kwan P, Arzimanoglu A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE commission on therapeutic strategies. Epilepsia 51:1069–1077CrossRefPubMed Kwan P, Arzimanoglu A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE commission on therapeutic strategies. Epilepsia 51:1069–1077CrossRefPubMed
21.
go back to reference Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133:2734–2748CrossRefPubMedPubMedCentral Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133:2734–2748CrossRefPubMedPubMedCentral
22.
go back to reference Pettingill P, Kramer HB, Coebergh JA, Pettingill R, Maxwell S, Nibber A et al (2015) Antibodies to GABAA receptor α1 and γ2 subunits: clinical and serologic characterization. Neurology 84:1233–1241CrossRefPubMedPubMedCentral Pettingill P, Kramer HB, Coebergh JA, Pettingill R, Maxwell S, Nibber A et al (2015) Antibodies to GABAA receptor α1 and γ2 subunits: clinical and serologic characterization. Neurology 84:1233–1241CrossRefPubMedPubMedCentral
23.
go back to reference Waters P, Woodhall M, O’Connor KC, Reindl M, Lang B, Sato DK et al (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2:e89CrossRefPubMedPubMedCentral Waters P, Woodhall M, O’Connor KC, Reindl M, Lang B, Sato DK et al (2015) MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm 2:e89CrossRefPubMedPubMedCentral
24.
go back to reference Zandi MS, Paterson RW, Ellul MA, Jacobson L, Al-Diwani A, Jones JL et al (2015) Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes. J Neurol Neurosurg Psychiatry 86:708–713CrossRefPubMed Zandi MS, Paterson RW, Ellul MA, Jacobson L, Al-Diwani A, Jones JL et al (2015) Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes. J Neurol Neurosurg Psychiatry 86:708–713CrossRefPubMed
25.
go back to reference Stefan H, Pauli E, Kerling F, Schwarz A, Koebnick C (2002) Autonomic auras: left hemispheric predominance of epileptic generators of cold shivers and goose bumps? Epilepsia 43:41–45CrossRefPubMed Stefan H, Pauli E, Kerling F, Schwarz A, Koebnick C (2002) Autonomic auras: left hemispheric predominance of epileptic generators of cold shivers and goose bumps? Epilepsia 43:41–45CrossRefPubMed
26.
go back to reference Dove GH, Buchhalter JR, Cascino GD (2004) Acute repetitive pilomotor seizures (goose bumps) in a patient with right mesial temporal sclerosis. Clin Neurophysiol 115:2511–2513CrossRefPubMed Dove GH, Buchhalter JR, Cascino GD (2004) Acute repetitive pilomotor seizures (goose bumps) in a patient with right mesial temporal sclerosis. Clin Neurophysiol 115:2511–2513CrossRefPubMed
27.
go back to reference Meo R, Bilo L, Striano S, Ruosi P, Estraneo A, Nocerino C (1995) Transient global amnesia of epileptic origin accompanied by fever. Seizure 4:311–317CrossRefPubMed Meo R, Bilo L, Striano S, Ruosi P, Estraneo A, Nocerino C (1995) Transient global amnesia of epileptic origin accompanied by fever. Seizure 4:311–317CrossRefPubMed
28.
go back to reference Rossetti AO, Tosi C, Despland PA, Staedler C (2007) Post-ictal fever: a rare symptom of partial seizures. Eur J Neurol 14:586–590CrossRefPubMed Rossetti AO, Tosi C, Despland PA, Staedler C (2007) Post-ictal fever: a rare symptom of partial seizures. Eur J Neurol 14:586–590CrossRefPubMed
29.
go back to reference Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N et al (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127:701–712CrossRefPubMed Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N et al (2004) Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127:701–712CrossRefPubMed
30.
go back to reference Thieben M, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S (2004) Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62:1177–1182CrossRefPubMed Thieben M, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S (2004) Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 62:1177–1182CrossRefPubMed
31.
go back to reference Parisi P, Striano P, Villa MP, Belcastro V (2013) Ictal epileptic headache: terms do matter in clinical practice! Reply to Cianchetti et al. Cephalalgia 33:426CrossRefPubMed Parisi P, Striano P, Villa MP, Belcastro V (2013) Ictal epileptic headache: terms do matter in clinical practice! Reply to Cianchetti et al. Cephalalgia 33:426CrossRefPubMed
32.
go back to reference Titulaer MJ, McCracken L, Gabilondo L, Armangué T, Glaser C, Iizuka T et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157–165CrossRefPubMedPubMedCentral Titulaer MJ, McCracken L, Gabilondo L, Armangué T, Glaser C, Iizuka T et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157–165CrossRefPubMedPubMedCentral
33.
go back to reference Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J (2013) Frequency and characteristics of isolated psychiatric episodes in anti-n-methyl-d-aspartate receptor encephalitis. JAMA Neurol 70:1133–1139CrossRefPubMed Kayser MS, Titulaer MJ, Gresa-Arribas N, Dalmau J (2013) Frequency and characteristics of isolated psychiatric episodes in anti-n-methyl-d-aspartate receptor encephalitis. JAMA Neurol 70:1133–1139CrossRefPubMed
34.
go back to reference Zandi MS, Irani SR, Lang B, Waters P, Jones PB, McKenna P et al (2011) Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 258:686–688CrossRefPubMedPubMedCentral Zandi MS, Irani SR, Lang B, Waters P, Jones PB, McKenna P et al (2011) Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 258:686–688CrossRefPubMedPubMedCentral
35.
go back to reference Pollak TA, Nicholson TR, Mellers JD, Vincent A, David AS (2014) Epilepsy-related psychosis: a role for autoimmunity? Epilepsy Behav 36:33–38CrossRefPubMed Pollak TA, Nicholson TR, Mellers JD, Vincent A, David AS (2014) Epilepsy-related psychosis: a role for autoimmunity? Epilepsy Behav 36:33–38CrossRefPubMed
36.
go back to reference Kuba R, Brazdil M, Rektor I (2012) Postictal psychosis and its electrophysiological correlates in invasive EEG: a case report study and literature review. Epilepsy Behav 23:426–430CrossRefPubMed Kuba R, Brazdil M, Rektor I (2012) Postictal psychosis and its electrophysiological correlates in invasive EEG: a case report study and literature review. Epilepsy Behav 23:426–430CrossRefPubMed
37.
go back to reference Takeda Y, Inoue Y, Tottori T, Mihara T (2001) Acute psychosis during intracranial EEGmonitoring: close relationship between psychotic symptoms and discharges in amygdala. Epilepsia 42:719–724CrossRefPubMed Takeda Y, Inoue Y, Tottori T, Mihara T (2001) Acute psychosis during intracranial EEGmonitoring: close relationship between psychotic symptoms and discharges in amygdala. Epilepsia 42:719–724CrossRefPubMed
38.
go back to reference Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A et al (2007) Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36CrossRefPubMedPubMedCentral Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A et al (2007) Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36CrossRefPubMedPubMedCentral
39.
go back to reference Viaccoz Desestret V, Ducray F, Picard G, Cavillon G, Rogemond V et al (2014) Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology 82:556–563CrossRefPubMed Viaccoz Desestret V, Ducray F, Picard G, Cavillon G, Rogemond V et al (2014) Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology 82:556–563CrossRefPubMed
40.
go back to reference Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D (2012) Extreme delta brush a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 79:1094–1100CrossRefPubMedPubMedCentral Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D (2012) Extreme delta brush a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 79:1094–1100CrossRefPubMedPubMedCentral
41.
go back to reference Johnson N, Henry C, Fessler AJ, Dalmau J (2010) Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology 75:1480–1482CrossRefPubMedPubMedCentral Johnson N, Henry C, Fessler AJ, Dalmau J (2010) Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus. Neurology 75:1480–1482CrossRefPubMedPubMedCentral
42.
go back to reference Kirkpatrick MP, Clarke CD, Sonmezturk HH, Abou-Khalil B (2011) Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis. Epilepsy Behav 20:392–394CrossRefPubMed Kirkpatrick MP, Clarke CD, Sonmezturk HH, Abou-Khalil B (2011) Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis. Epilepsy Behav 20:392–394CrossRefPubMed
43.
go back to reference Malter MP, Frisch C, Zeitler H, Surges R, Urbach H, Helmstaedter C et al (2015) Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies. Seizure 30:57–63CrossRefPubMed Malter MP, Frisch C, Zeitler H, Surges R, Urbach H, Helmstaedter C et al (2015) Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies. Seizure 30:57–63CrossRefPubMed
44.
go back to reference Bien CG, Vincent A, Barnett MH, Becker AJ, Blümcke I, Graus F et al (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 135:1622–1638CrossRefPubMed Bien CG, Vincent A, Barnett MH, Becker AJ, Blümcke I, Graus F et al (2012) Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis. Brain 135:1622–1638CrossRefPubMed
45.
go back to reference Errichiello L, Perruolo G, Pascarella A, Formisano P, Minetti C, Striano S et al (2009) Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients. J Neuroimmunol 211:120–123CrossRefPubMed Errichiello L, Perruolo G, Pascarella A, Formisano P, Minetti C, Striano S et al (2009) Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients. J Neuroimmunol 211:120–123CrossRefPubMed
Metadata
Title
Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings
Authors
Leyla Baysal-Kirac
Erdem Tuzun
Ece Erdag
Canan Ulusoy
Ebru Nur Vanli-Yavuz
Esme Ekizoglu
Sian Peach
Mine Sezgin
Nerses Bebek
Candan Gurses
Aysen Gokyigit
Angela Vincent
Betul Baykan
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 3/2016
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-8002-2

Other articles of this Issue 3/2016

Journal of Neurology 3/2016 Go to the issue